Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline adjunct in MDD
NCT02456948Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in major depressive disorder (MDD), sponsored by Charité – Universitätsmedizin Berlin. Started Jan 2015; status: completed.
02
Drugs
minocycline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02456948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456948.